Longboard Pharmaceuticals (LBPH) - רווח צפוי

Longboard Pharmaceuticals (LBPH) relies on an academic approach and a strong team of neurobiologists. Targeted action on GPCR receptors paves the way for leadership in epilepsy treatment, while a focus on Phase 3 clinical trials enhances R&D potential. The projected financial result reflects market expectations, where the final value of the parameter equals , helping to assess the company's future profits.
פילוחי מדדים מקיפים ואנליטיקה עבור Longboard (LBPH)

Investors must critically assess the risks of Longboard Pharmaceuticals (LBPH) before entering the asset. Longboard Pharmaceuticals (LBPH) is currently focused exclusively on the final stages of trials for its epilepsy drug. Analyzing the prospective profit chart, you can see a consolidated forecast of future revenues based on the expected market success of R&D. This metric measures the potential capitalization of future cash flows, confirming the fundamental stability of the business prior to acquisition.